Low Revascularization of Experimentally Transplanted Human Pancreatic Islets
Per-Ola Carlsson,
Fredrik Palm and
Göran Mattsson
Departments of Medical Cell Biology (P.-O.C., F.P., G.M.) and Diagnostic Radiology (F.P.), Uppsala University, SE-751 23 Uppsala, Sweden
Address all correspondence and requests for reprints to: Per-Ola Carlsson, M.D., Ph.D., Department of Medical Cell Biology, Biomedical Center, Husargatan 3, Box 571, SE-751 23 Uppsala, Sweden. E-mail: per-ola.carlsson{at}medcellbiol.uu.se.
Abstract
Pancreatic islets are avascular immediately after transplantation.Although the islets are rapidly revascularized, it is uncertainwhether the revascularization produces an adequate oxygenationof the transplanted islet tissue. We measured pO2, blood flowand vascular density in mouse or human islets 1 month aftertransplantation to nude mice. Tissue pO2 was measured with Clarkmicroelectrodes. Blood perfusion was measured with laser-Dopplerflow cytometry, whereas vascular density was determined in histologicalspecimens stained for the lectin Bandeiraea simplicifolia (BS-1).Both the transplanted mouse and human islets had a pO2 1520%of that in endogenous mouse islets. Moreover, the vascular densityof the transplanted islets was decreased compared with thatof endogenous mouse and human islets. Graft blood perfusionwas approximately 50% of renal cortex blood flow. A negativecorrelation was found between donor age and blood perfusionof the human islet grafts. A similar correlation was seen betweendonor age and the total vascular density of these grafts. Inconclusion, transplanted human islets had a markedly decreasedvascular density and pO2 compared with endogenous islets. Thishas potential implications for clinical islet transplantations,because poor vascular engraftment may significantly increasethe number of islets needed to obtain insulin independence.
This article has been cited by other articles:
M. Johansson, J. Olerud, L. Jansson, and P.-O. Carlsson Prolactin Treatment Improves Engraftment and Function of Transplanted Pancreatic Islets
Endocrinology,
April 1, 2009;
150(4):
1646 - 1653.
[Abstract][Full Text][PDF]
X. Huang, D. J. Moore, R. J. Ketchum, C. S. Nunemaker, B. Kovatchev, A. L. McCall, and K. L. Brayman Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation
Endocr. Rev.,
August 1, 2008;
29(5):
603 - 630.
[Abstract][Full Text][PDF]
J. Olerud, M. Johansson, J. Lawler, N. Welsh, and P.-O. Carlsson Improved Vascular Engraftment and Graft Function After Inhibition of the Angiostatic Factor Thrombospondin-1 in Mouse Pancreatic Islets
Diabetes,
July 1, 2008;
57(7):
1870 - 1877.
[Abstract][Full Text][PDF]
J. A. Emamaullee, J. Davis, R. Pawlick, C. Toso, S. Merani, S.-X. Cai, B. Tseng, and A.M. J. Shapiro The Caspase Selective Inhibitor EP1013 Augments Human Islet Graft Function and Longevity in Marginal Mass Islet Transplantation in Mice
Diabetes,
June 1, 2008;
57(6):
1556 - 1566.
[Abstract][Full Text][PDF]
A. J.F. King, J. R. Fernandes, J. Hollister-Lock, C. E. Nienaber, S. Bonner-Weir, and G. C. Weir Normal Relationship of {beta}- and Non {beta}-Cells Not Needed for Successful Islet Transplantation
Diabetes,
September 1, 2007;
56(9):
2312 - 2318.
[Abstract][Full Text][PDF]
J. A. Emamaullee, L. Stanton, C. Schur, and A.M. J. Shapiro Caspase Inhibitor Therapy Enhances Marginal Mass Islet Graft Survival and Preserves Long-Term Function in Islet Transplantation
Diabetes,
May 1, 2007;
56(5):
1289 - 1298.
[Abstract][Full Text][PDF]
J. Gromada, I. Franklin, and C. B. Wollheim {alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev.,
February 1, 2007;
28(1):
84 - 116.
[Abstract][Full Text][PDF]
J. A. Emamaullee and A.M. J. Shapiro Interventional Strategies to Prevent {beta}-Cell Apoptosis in Islet Transplantation.
Diabetes,
July 1, 2006;
55(7):
1907 - 1914.
[Abstract][Full Text][PDF]
M. Brissova, M. Fowler, P. Wiebe, A. Shostak, M. Shiota, A. Radhika, P. C. Lin, M. Gannon, and A. C. Powers Intraislet Endothelial Cells Contribute to Revascularization of Transplanted Pancreatic Islets
Diabetes,
May 1, 2004;
53(5):
1318 - 1325.
[Abstract][Full Text][PDF]
G. Mattsson, L. Jansson, A. Nordin, A. Andersson, and P.-O. Carlsson Evidence of Functional Impairment of Syngeneically Transplanted Mouse Pancreatic Islets Retrieved from the Liver
Diabetes,
April 1, 2004;
53(4):
948 - 954.
[Abstract][Full Text][PDF]
R. P. Robertson Islet Transplantation as a Treatment for Diabetes -- A Work in Progress
N. Engl. J. Med.,
February 12, 2004;
350(7):
694 - 705.
[Full Text][PDF]
A. Omer, V. F. Duvivier-Kali, W. Aschenbach, V. Tchipashvili, L. J. Goodyear, and G. C. Weir Exercise Induces Hypoglycemia in Rats With Islet Transplantation
Diabetes,
February 1, 2004;
53(2):
360 - 365.
[Abstract][Full Text]
V. Mathews, P. T. Hanson, E. Ford, J. Fujita, K. S. Polonsky, and T. A. Graubert Recruitment of Bone Marrow-Derived Endothelial Cells to Sites of Pancreatic {beta}-Cell Injury
Diabetes,
January 1, 2004;
53(1):
91 - 98.
[Abstract][Full Text][PDF]
R. P. Robertson Intrahepatically Transplanted Islets--Strangers in a Strange Land
J. Clin. Endocrinol. Metab.,
December 1, 2002;
87(12):
5416 - 5417.
[Full Text][PDF]